Cancer Statistics, 2017.

PubWeight™: 4.77‹?› | Rank: Top 1%

🔗 View Article (PMID 28055103)

Published in CA Cancer J Clin on January 05, 2017

Authors

Rebecca L Siegel1, Kimberly D Miller2, Ahmedin Jemal3

Author Affiliations

1: Strategic Director, Surveillance Information Services, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.
2: Epidemiologist, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.
3: Vice President, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.

Articles citing this

(truncated to the top 100)

Phylogenetic ctDNA analysis depicts early stage lung cancer evolution. Nature (2017) 2.54

Press-pulse: a novel therapeutic strategy for the metabolic management of cancer. Nutr Metab (Lond) (2017) 0.85

The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients. Int J Mol Sci (2017) 0.77

Recent advances of highly selective CDK4/6 inhibitors in breast cancer. J Hematol Oncol (2017) 0.77

EMT and MET: necessary or permissive for metastasis? Mol Oncol (2017) 0.77

MicroRNAs in Gynecological Cancers: Small molecules with big implications. Cancer Lett (2017) 0.76

Long noncoding RNA HEIH promotes melanoma cell proliferation, migration and invasion via inhibition of miR-200b/a/429. Biosci Rep (2017) 0.76

Expression profile of SIRT2 in human melanoma and implications for sirtuin-based chemotherapy. Cell Cycle (2017) 0.76

Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway. Sci Rep (2017) 0.75

Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes. Cancer Lett (2017) 0.75

Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment. Cancers (Basel) (2017) 0.75

Role of steroid receptor and coregulator mutations in hormone-dependent cancers. J Clin Invest (2017) 0.75

Antiangiogenic effects of oridonin. BMC Complement Altern Med (2017) 0.75

High expression of PLA2G16 is associated with a better prognosis in HER2-positive breast cancer. J Thorac Dis (2017) 0.75

The role of GLI1 for 5-Fu resistance in colorectal cancer. Cell Biosci (2017) 0.75

HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. J Exp Clin Cancer Res (2017) 0.75

Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer. Trends Mol Med (2017) 0.75

The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis. Oncotarget (2017) 0.75

Ultrasound mediated delivery of oxygen and LLL12 loaded stimuli responsive microdroplets for the treatment of hypoxic cancer cells. Sci Rep (2017) 0.75

Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward. Int J Mol Sci (2017) 0.75

Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference? Int J Environ Res Public Health (2017) 0.75

Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway. Mol Med Rep (2017) 0.75

Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling. Front Pharmacol (2017) 0.75

Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2. J Exp Clin Cancer Res (2017) 0.75

Re-engineering the Pancreas Tumor Microenvironment: A "Regenerative Program" Hacked. Clin Cancer Res (2017) 0.75

Skin Cancer: Have melanoma and skin cancer finally met their match? Nat Rev Clin Oncol (2017) 0.75

CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo. PLoS One (2017) 0.75

BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population. Oncotarget (2017) 0.75

Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population. Aging (Albany NY) (2017) 0.75

Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer. Sci Rep (2017) 0.75

Alisertib induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells. Am J Transl Res (2017) 0.75

Chemotherapy Resistance Mechanisms in Advanced Skin Cancer. Oncol Rev (2017) 0.75

Management of testicular cancer: NYU case of the month, March 2017. Rev Urol (2017) 0.75

Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy. PLoS One (2017) 0.75

Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. J Surg Oncol (2017) 0.75

The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes. Oncotarget (2017) 0.75

Perspective of αvβ6-Integrin Imaging for Clinical Management of Pancreatic Carcinoma and Its Precursor Lesions. Mol Imaging (2017) 0.75

Eosinophilic funiculitis initially diagnosed as irreducible inguinal hernia: A case report. Int J Surg Case Rep (2017) 0.75

The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. BMC Cancer (2017) 0.75

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review. Cancers (Basel) (2017) 0.75

Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis. Cancer Causes Control (2017) 0.75

Improving Self-Efficacy and Self-Care in Adult Patients With a Urinary Diversion: A Pilot Study. Oncol Nurs Forum (2017) 0.75

Repeatability of [(68)Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate Cancer. Mol Imaging Biol (2017) 0.75

Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles. Exp Biol Med (Maywood) (2017) 0.75

A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma. Oncologist (2017) 0.75

Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis. Oncol Lett (2017) 0.75

Current advances in endocrine therapy options for premenopausal women with hormone receptor positive breast cancer. Gynecol Oncol (2017) 0.75

Anticancer effects of β-elemene with hyperthermia in lung cancer cells. Exp Ther Med (2017) 0.75

Potential impact of the Affordable Care Act's preventive services provision on breast cancer stage: A preliminary assessment. Cancer Epidemiol (2017) 0.75

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions. Eur J Nucl Med Mol Imaging (2017) 0.75

Hereditary pancreatic cancer: related syndromes and clinical perspective. Hered Cancer Clin Pract (2017) 0.75

Multiple roles of RARRES1 in prostate cancer: Autophagy induction and angiogenesis inhibition. PLoS One (2017) 0.75

Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis. J Gynecol Oncol (2017) 0.75

Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients (2017) 0.75

Analysis of aqueous humor concentrations of cytokines in retinoblastoma. PLoS One (2017) 0.75

GeNNet: an integrated platform for unifying scientific workflows and graph databases for transcriptome data analysis. PeerJ (2017) 0.75

Genetic Variants in the Genes Encoding Rho GTPases and Related Regulators Predict Cutaneous Melanoma-specific Survival. Int J Cancer (2017) 0.75

Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer. Exp Ther Med (2017) 0.75

Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer. Medicine (Baltimore) (2017) 0.75

Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach. Front Oncol (2017) 0.75

Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer. Clin Cancer Res (2017) 0.75

Childhood and teenage physical activity and breast cancer risk. Breast Cancer Res Treat (2017) 0.75

Progress in the application and mechanism of metformin in treating non-small cell lung cancer. Oncol Lett (2017) 0.75

Synergy of Iron Chelators and Therapeutic Peptide Sequences Delivered via a Magnetic Nanocarrier. J Funct Biomater (2017) 0.75

New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. J Clin Transl Hepatol (2017) 0.75

LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions. Mod Pathol (2017) 0.75

Sphingosine kinase 1 expression enhances colon tumor growth. J Transl Med (2017) 0.75

Diagnostic MicroRNA Biomarker Discovery for Non-Small-Cell Lung Cancer Adenocarcinoma by Integrative Bioinformatics Analysis. Biomed Res Int (2017) 0.75

Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis. Onco Targets Ther (2017) 0.75

The modified frailty index to predict morbidity and mortality for retroperitoneal sarcoma resections. J Surg Res (2017) 0.75

The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment. Eur J Pharmacol (2017) 0.75

Body mass index and persistent pain after breast cancer surgery: findings from the women's healthy eating and living study and a meta-analysis. Oncotarget (2017) 0.75

The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy. Int J Mol Sci (2017) 0.75

A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. Clinicoecon Outcomes Res (2017) 0.75

Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochim Biophys Acta (2017) 0.75

Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells. Int J Mol Sci (2017) 0.75

Mode of Action Analyses of Neferine, a Bisbenzylisoquinoline Alkaloid of Lotus (Nelumbo nucifera) against Multidrug-Resistant Tumor Cells. Front Pharmacol (2017) 0.75

Clinical applications of genome studies. Hematol Oncol (2017) 0.75

Are we underestimating the rates of incontinence after prostate cancer treatment? Results from NHANES. Int Urol Nephrol (2017) 0.75

The potential of organoids in urological cancer research. Nat Rev Urol (2017) 0.75

Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression. Nucleic Acids Res (2017) 0.75

Assessment and Improvement of Quality of Life in Patients Undergoing Treatment for Head and Neck Cancer. Cureus (2017) 0.75

Conditional abrogation of Transforming Growth Factor Beta Receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice. J Pathol (2017) 0.75

Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile. Mol Imaging Biol (2017) 0.75

Drug Delivery to Melanoma Brain Metastases: Can Current Challenges Lead to New Opportunities? Pharmacol Res (2017) 0.75

Testicular versus adrenal sources of hydroxyandrogens in prostate cancer. Endocr Relat Cancer (2017) 0.75

Quantifying the genetic correlation between multiple cancer types. Cancer Epidemiol Biomarkers Prev (2017) 0.75

Involvement of glycogen debranching enzyme in bladder cancer. Biomed Rep (2017) 0.75

Targeting Ongoing DNA Damage in Multiple Myeloma: Effects of DNA Damage Response Inhibitors on Plasma Cell Survival. Front Oncol (2017) 0.75

Elotuzumab as a Novel Anti-Myeloma Immunotherapy. Hum Vaccin Immunother (2017) 0.75

Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer. Br J Radiol (2017) 0.75

24-Methyl-Cholesta-5,24(28)-Diene-3β,19-diol-7β-Monoacetate Inhibits Human Small Cell Lung Cancer Growth In Vitro and In Vivo via Apoptosis Induction. Mar Drugs (2017) 0.75

Targeted therapies for renal cell carcinoma. Nat Rev Nephrol (2017) 0.75

Prostate cancer downregulated SIRP-α modulates apoptosis and proliferation through p38-MAPK/NF-κB/COX-2 signaling. Oncol Lett (2017) 0.75

Targeting cancer stem cells for chemoprevention of pancreatic cancer. Curr Med Chem (2017) 0.75

Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock? Target Oncol (2017) 0.75

Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction. Breast Cancer Res Treat (2017) 0.75

The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study. Prostate Cancer Prostatic Dis (2017) 0.75

Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications. Cancers (Basel) (2017) 0.75

Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review. Curr Urol Rep (2017) 0.75